The COMPASS Study – Community Prevalence of SARS-CoV-2 Study (CoVPN 5002) will estimate the percentage of people affected by SARS-CoV-2, the virus that causes COVID-19, in selected communities in the United States. It will:
- Evaluate the extent of COVID-19 in these communities
- Assess knowledge, attitudes and behaviors related to SARS-CoV-2 and COVID-19
- Model the potential impact of different prevention interventions
- Guide future SARS-CoV-2 prevention studies and COVID-19 treatment studies in these communities
The study will also provide valuable samples for important laboratory assessments related to the acquisition of SARS-CoV-2 and impact of the COVID-19 pandemic.